Akèy › Twoub depresif majè › Kalifòni › Orange
Etid klinik pou Twoub depresif majè nan Orange, CA
13 etid pou Twoub depresif majè ap chèche patisipan nan sit nan ak bò kote Orange (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
Ap rekriteFaz 2
- PNS Clinical Research LLC dba ATP Clinical Research, Orange
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
Ap rekriteFaz 3
- ATP Clinical Research, Orange
- NRC Research Institute, Orange
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
Ap rekriteFaz 3
- ATP Clinical Research Orange County, Orange
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
Ap rekriteFaz 3
- ATP Clinical Research, Orange
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
Ap rekriteFaz 3
- NRC Research Institute, Orange
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
Ap rekriteFaz 2
- Nrc Research Institute, Orange
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
Ap rekriteFaz 3
- Vanda Investigational Site, Orange
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
Ap rekriteFaz 4
- Neurocrine Clinical Site, Orange
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
Ap rekriteFaz 3
- Atp Clinical Research, Orange
- Nrc Research Institute, Orange
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Ap rekriteFaz 3
- Neurocrine Clinical Site, Orange
A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Ap rekriteFaz 3
- Neurocrine Clinical Site, Orange
Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
Ap rekriteFaz 2
- Autobahn Site #152, Orange
Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Ap rekriteFaz 3
- Neurocrine Clinical Site, Orange
Etid Twoub depresif majè nan lòt vil
- New York City, NY36 etid
- Boston, MA31 etid
- Atlanta, GA25 etid
- Philadelphia, PA23 etid
- Orlando, FL19 etid
- Miami, FL18 etid
- Chicago, IL17 etid
- Tampa, FL17 etid
- San Diego, CA16 etid
- Houston, TX16 etid
- Little Rock, AR14 etid
- Austin, TX13 etid
Lòt etid nan Orange
- Kansè Poumon ki pa ti selil25 etid
- Kansè Metastatik20 etid
- Kansè kolorektal16 etid
- Kansè ovè16 etid
- Kansè pankreyas15 etid
- Melanom14 etid
- Kansè fwa (Kasinòm epatoselilè)14 etid
- Kansè nan tete14 etid
- Kansè poumon14 etid
- Kansè pwostat14 etid
- Kansè lestomak13 etid
- Kansè (tout kalite)13 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.